Literature DB >> 6941210

Recovery of left ventricular function following discontinuation of anthracycline chemotherapy in children.

A B Lewis, V L Crouse, W Evans, M Takahashi, S E Siegel.   

Abstract

Echocardiographic evaluation of left ventricular (LV) performance was performed in 41 children during and following anthracycline chemotherapy. Prior to treatment LV function was normal in all patients; LV shortening fraction was 35.2 +/- 0.7% and percent of predicted velocity of circumferential fiber shortening was 110 +/- 20%. However, the indices measured concurrent with the final anthracycline dose (mean = 308 +/- 16 mg/sq m) demonstrated a significant decline in LV function. The LV shortening fraction had decreased to 29.5 +/- 0.8% and percent of predicted velocity of circumferential fiber shortening decreased to 94 +/- 4% (P less than .01). Four of the eight patients with evidence of significant LV dysfunction had received thoracic or upper abdominal irradiation. Following cessation of anthracycline therapy, LV function improved within one to six months and had returned to normal in all but two patients, both of whom received irradiation. Echocardiography is useful for the identification of anthracycline-induced LV dysfunction. With discontinuation of further anthracycline administration the functional decline in LV performance appears to be reversible.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6941210

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  4 in total

1.  Perioperative complications in patients with anthracycline chemotherapeutic agents.

Authors:  F A Burrows; P R Hickey; S Colan
Journal:  Can Anaesth Soc J       Date:  1985-03

Review 2.  Current views on anthracycline cardiotoxicity.

Authors:  Donato Mele; Marianna Nardozza; Paolo Spallarossa; Antonio Frassoldati; Carlo G Tocchetti; Christian Cadeddu; Rosalinda Madonna; Michele Malagù; Roberto Ferrari; Giuseppe Mercuro
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

3.  Early identification of anthracycline cardiomyopathy: possibilities and implications.

Authors:  F A Bu'Lock; M G Mott; A Oakhill; R P Martin
Journal:  Arch Dis Child       Date:  1996-11       Impact factor: 3.791

4.  Doxorubicin cardiomyopathy is associated with a decrease in calcium release channel of the sarcoplasmic reticulum in a chronic rabbit model.

Authors:  D A Dodd; J B Atkinson; R D Olson; S Buck; B J Cusack; S Fleischer; R J Boucek
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.